Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2001

View Archived Issues

Active Biotech updates development programs

Exisulind may delay disease progression in prostate cancer patients

Copaxone reduces the percentage of permanent "black holes" in MS

Raven Biotechnologies delivers first MAb to ImmunoGen in ovarian cancer research collaboration

Matrix to seek E.U. approval of IntraDose by Q4 2001

Myriad Genetics uncovers potential of MPI-176716 as broad-spectrum cancer treatment

VaxGen receives further funding from NIH for HIV vaccine development

PLG microsphere formulation of human beta-amyloid(1-42) induces significant serum antibody response

Lorus and Faulding establish Virulizin distribution agreement for Latin America

Licensing agreement announced for ramoplanin

Karo Bio updates KB-002611 clinical development

Platinum complexes simultaneously targeting DNA and thioredoxin reductase

Positive data presented for OC-1016, a novel bone- and tissue-regenerating agent

Daiichi presents chemistry and pharmacology for diaminobutane AMPA receptor antagonists

3-Dimensional Pharmaceuticals to receive milestone payment for thrombin inhibitor program

Gene therapy for B-cell malignancies heading for phase II testing

Avigen's Coagulin-B gene therapy for hemophilia B trial on clinical hold

Phase II trial of Argatroban plus gpIIb/IIIa antagonists initiated in patients undergoing PCI

Fully humanized antibody for diagnosis and therapy of cancer

Rotta presents new leukotriene antagonists related to tyrosine

New nitroacridine derivatives with excellent in vivo antitumor activity

Inhibitors of PDE5 for sexual dysfunction and other disorders in development in Korea

Merck continues to identify inhibitors of protein prenyltransferases

Beta3-adrenoceptor agonists and use in urinary incontinence, obesity and diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...